Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
Enlivex Therapeutics Ltd (ENLV)
Enlivex Therapeutics Ltd (ENLV) Financials

ENLV Enlivex Therapeutics Ltd

1.424

-0.066 (-4.43%)

Last Updated: 18:26:01

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-102.883	-24.829	-41.237	-65.636	-40.83	-21.354	-38.16	-55.647
Return on Equity (%)	-120.326	-29.13	-46.618	-89.423	-50.563	-24.008	-43.783	-66.881
Return on Invested Capital (%)	-120.908	-25.338	-58.588	-82.736	-42.004	-32.162	-36.596	-58.473
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	0.513	2.054	1.016	0.711	1.764	3.565	2.374	1.247
Earnings Per Share	-0.945	-0.641	-0.47	-0.592	-0.588	-0.606	-1.297	-1.205
Cash Per Share	0.405	2.304	1.078	0.344	0.34	0.47	2.086	0.034
Working Capital Per Share	0.508	2.154	1.013	0.658	1.678	3.426	1.909	1.148
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-0.932	-0.641	-0.47	-0.592	-0.588	-0.606	-1.297	-1.205
EBITDA Per Share	-0.932	-0.641	-0.47	-0.592	-0.588	-0.606	-1.297	-1.205
Free Cash Flow Per Share	-0.945	-0.629	-0.432	-0.593	-0.551	-0.561	-0.99	-1.23

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	5.459	13.095	9.095	2.746	8.719	18.322	7.92	5.571
Quick Ratio	5.115	12.938	8.651	2.259	8.453	17.832	7.605	4.508
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	16.39M	3.34M	3.51M	10.33M	14.59M	18.33M	18.42M	18.6M

Key Stats and Ratios

Year End 31 December 2023	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	18.37M	18.38M	18.41M	18.42M	18.57M	18.59M	18.6M	18.6M
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	13.808	N/A	N/A	N/A	6.892	N/A	N/A	N/A
Quick Ratio	13.582	N/A	N/A	N/A	6.618	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	26.16M
Price to Earnings Ratio	-0.9
Price to Sales Ratio	0
Price to Cash Ratio	32.2
Price to Book Ratio	0.87
Dividend Yield	-

Share Statistics

Shares Outstanding	18.42M
Average Volume (1 week)	43.9k
Average Volume (1 Month)	88.53k
52 Week Change	-48.03%
52 Week High	4.59
52 Week Low	1.15

More Ratios Coming Soon!

Enlivex Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions